Idera Pharmaceuticals, Inc.

IDRANASDAQHealthcare

$0.43

$-0.13(-23.04%)

Market Cap$0

P/E Ratio—

52W High$16.0

52W Low$0.4201

Avg Volume34K

Open$0.48

Beta0.00

Overview

Idera Pharmaceuticals, Inc.（IDRA）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

idra · 股价预测 · 9 位分析师（近3月）· FMP · 更新于 2025年8月27日

分析师评级与共识

基于过去 3 个月内 9 位华尔街分析师

Buy

9 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 9 · 买入占比: 55.6%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $0.42

Idera Pharmaceuticals, Inc.（IDRA）的分析师共识为 Buy，基于过去 3 个月内 9 位华尔街分析师的评级。IDRA 的 12 个月平均目标价为 $0.00，相对当前价 $0.42 代表 +0.0% 的潜在上行空间。

短期股价预测

📅

财报窗口期

在 ±3 天财报窗口期内暂停短期预测，以避免不可靠信号。

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

Year	Low	Avg Price	High	Change
2027	$0	$0	$0	-50.0%
2028	$0	$0	$0	-62.5%
2029	$0	$0	$0	-67.2%
2030	$0	$0	$0	-69.2%
2031	$0	—	$0	-70.2%

Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Elevated Volatility — Earnings Window Active (±3 days)· Technical signals still shown. M3 predictions paused.

Market Sentiment

NEUTRAL

Based on 14 technical indicators

43%7%50%

6Buy

1Neutral

7Sell

RSI (14)59.6Neutral

MACDBULLISH

Refreshes daily from EOD close

Moving Averages · IDRA · Jun 9, 2026

Simple Moving Average (SMA)

MA 5$0.50SELL

MA 10$0.55SELL

MA 20$0.41BUY

MA 50$0.37BUY

MA 100$0.40BUY

MA 200$0.44SELL

Current $IDRA · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$0.50SELL

EMA 10$0.50SELL

EMA 20$0.45SELL

EMA 50$0.40BUY

EMA 100$0.41BUY

EMA 200$0.47SELL

Current $IDRA · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2021-03-19	Wedbush	Downgrade ↓	Outperform→Neutral
2021-03-19	JMP Securities	Downgrade ↓	Outperform→Perform
2021-03-19	Barclays	Downgrade ↓	Overweight→Equal Weight
2021-03-19	HC Wainwright & Co.	Downgrade ↓	Buy→Neutral
2018-09-24	Barclays	Maintains	Overweight→Overweight
2018-07-16	Wedbush	Maintains	Outperform→Outperform
2018-06-13	Baird	Maintains	Outperform→Outperform
2018-06-13	JMP Securities	Maintains	Market Outperform→Outperform
2017-11-09	H.C. Wainwright	Maintains	Buy→Buy
2017-04-24	Baird	Maintains	Outperform→Outperform

Wedbush2021-03-19

Downgrade ↓

Outperform→Neutral

JMP Securities2021-03-19

Downgrade ↓

Outperform→Perform

Barclays2021-03-19

Downgrade ↓

Overweight→Equal Weight

HC Wainwright & Co.2021-03-19

Downgrade ↓

Buy→Neutral

Barclays2018-09-24

Maintains

Overweight→Overweight

Wedbush2018-07-16

Maintains

Outperform→Outperform

Baird2018-06-13

Maintains

Outperform→Outperform

JMP Securities2018-06-13

Maintains

Market Outperform→Outperform

H.C. Wainwright2017-11-09

Maintains

Buy→Buy

Baird2017-04-24

Maintains

Outperform→Outperform

Wall Street analysts have recently issued updated ratings on Idera Pharmaceuticals, Inc. (IDRA) stock. Of the recent 15 rating actions, 0 were upgrades and 4 were downgrades. 9 analysts currently cover IDRA.

分析师推荐趋势

Buy ratings1 → 0↓ 1

Hold ratings0 → 4↑ +4

Sell ratings0 → 0

IDRA analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

—

Revenue Next Year

—

EPS This Year

—

EPS Next Year

—

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast IDRA EPS of $— for the current fiscal year, based on estimates from 0 analysts. The IDRA revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

IDRA 股价预测由两类独立数据源支撑：来自 9 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。IDRA 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。

IDRA 对 2027 年的股价预测均值为 $0。 IDRA 对 2030 年的预测区间为 $0–$0。

Idera Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 IDRA。IDRA 在 2027 年的整体展望偏积极，在覆盖分析师中约 56% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

IDRA 预测 · 8 个问题

根据 9 位华尔街分析师，IDRA 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $0.42，隐含约 +0.0% 的上行空间。

IDRA 目标价IDRA 分析师目标价IDRA 12个月目标价目标价 IDRA

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.